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Abstract 
Background: Prevalence of chronic gastrointestinal diseases has been rising amongst ethnic minority populations 
in Western countries, despite the first-generation migrants originating from countries of low prevalence. Differences 
caused by genetic, environmental, cultural, and religious factors in each context may contribute towards shaping 
experiences of ethnic minority individuals living with primary bowel conditions. This review aimed to explore the 
experiences of ethnic minority patients living with chronic bowel conditions.
Methods: We conducted a systematic scoping review to retrieve qualitative, quantitative, and mixed methods stud-
ies from eight electronic databases, and manually searched reference lists of frequently cited papers.
Results: Fourteen papers met the inclusion criteria: focussing on inflammatory bowel disease, irritable bowel 
syndrome, and coeliac disease. Core themes were narratively analysed. South Asians had limited understanding of 
inflammatory bowel disease and coeliac disease, hindered by language and literacy barriers, particularly for older 
generations, suggesting that culturally relevant information is needed. Family support was limited, and Muslim South 
Asians referred to religion to understand and self-manage inflammatory bowel disease. Ethnic minority groups across 
countries experienced: poor dietary intake for coeliac disease and inflammatory bowel disease, cultural conflict in 
self-managing diet for inflammatory bowel disease which increased anxiety, and there was a need for better qual-
ity of, and access to, healthcare services. British ethnic minority groups experienced difficulties with IBD diagnosis/
misdiagnosis.
Conclusions: Cultural, religious, and social contexts, together with language barriers and limited health literacy influ-
enced experiences of health inequalities for ethnic minority patients living with chronic bowel diseases.
Keywords: Coeliac Disease, Crohn’s Disease, Ethnic minority, Experiences, Inflammatory Bowel Disease, Irritable 
Bowel Syndrome, Systematic scoping review, Ulcerative Colitis
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Background
Chronic bowel illnesses have been rising in ethnic minor-
ity populations, though experiences of patients in ethnic 
minority groups have been largely underexplored [1–5]. 
Common bowel conditions include Inflammatory Bowel 
Disease (IBD): an umbrella term that covers various con-
ditions causing gastrointestinal inflammation includ-
ing Crohn’s Disease (CD) and Ulcerative Colitis (UC); 
Irritable Bowel Disease (IBS): where  recurrent abdomi-
nal pain/discomfort has an impact on defecation and 
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changes in bowel habits, but physiological changes to 
confirm diagnosis are absent [6–8]; and coeliac disease: 
an auto-immune condition arising from a dysregulated 
immune response to gluten (a  storage protein found in 
wheat, barley, and rye) in the diet, where the reaction to 
gluten damages the enteral villi causing shortening and 
blunting which decreases the surface area of the mucosa 
and thus affects absorption of nutrients from the gut [9]. 
All three bowel conditions are characterised by symp-
toms of abdominal pain, rectal bleeding, fatigue, urgency, 
and diarrhoea, and are usually diagnosed via colonos-
copy and/or endoscopy [8, 9].
Earlier studies have shown that IBD prevalence has 
been geographically distributed in Northern/Western 
European, North American, and Australian White popu-
lations [10–12]. Similar trends have also been observed 
in North American and Western European White popu-
lations for IBS [4, 5, 13], and across White populations 
in Europe for coeliac disease [9, 14]. Those who have 
migrated from low prevalence countries (e.g., South Asia) 
to high prevalence countries (e.g., UK) and their off-
spring, seem to have higher rates of some chronic bowel 
conditions than the indigenous population including 
IBD [15–19] and coeliac disease [14]. Genetic suscepti-
bility, and cultural and environmental influences may 
play a part in shaping the diverse experiences of ethnic 
minority populations, raising important implications for 
disease management and intervention development for 
these communities, which need to be better understood 
[20–24].
Byron et al. [22] framed experiences of chronic bowel 
illnesses as distinct daily ‘challenges’ that increase dis-
ease activity, whether physical (e.g., fatigue) and/or 
psychosocial (e.g., anxiety), and reasoned that people 
adapt to self-manage these challenges (e.g., awareness 
of and being proximal to bathroom facilities), although 
little is known about the challenges that exist in ethnic 
minority groups. Dietary changes in these groups can 
be affected by migration (e.g., accessibility and the avail-
ability of traditional diets or ingredients such as fresh 
fish) and acculturation (e.g., dietary modifications to 
assimilate with food choices of indigenous groups such 
as processed food), which may affect the gut microbiome 
[1, 15–17, 25]. To illustrate this, Limdi et al. [26] found 
significant differences between British South Asians 
and White patients’ beliefs, perceptions, and behaviours 
around IBD and dieting/food avoidance, even though 
South Asians comprised of a small cohort. More South 
Asians restricted their diet to avoid relapses and eat-
ing outdoors. They had a greater belief that diet con-
tributed to disease initiation and controlled IBD better 
than medication. Similar findings were also reported in 
another UK based study with a larger number of partici-
pants [27]. A Gluten Free Diet (GFD) can be an effective 
but challenging way of managing coeliac disease, since 
a GFD necessitates pre-existing knowledge or access to 
information, motivation, and availability of GF food, and 
avoidance of habitual/traditional gluten heavy food (e.g., 
chapati for Punjabis) requires cultural advice [14, 28, 29]. 
Adam et  al. [30] found significant differences in adher-
ence to GFD (64.6% vs. 12.1%) and vitamin D deficiency 
(70.8% vs. 32.8%) between British Caucasians and South 
Asians, despite the latter group comprising of a smaller 
cohort.
Heterogeneity in disease phenotype in ethnic minor-
ity groups can be influenced by differential cultural 
and environmental exposures (e.g., pollutants, smok-
ing, and microbial exposure) forming a generational 
impact [15, 31]. Misra et  al. [31] found that height-
ened genetic susceptibility and environmental triggers 
may have promoted the risk of developing UC with a 
non-colonic phenotype for British Indian patients, 
and most second-generation Indians (aged 15–40) 
had higher age-adjusted incidence of UC compared 
to White Europeans and Pakistanis, indicating that 
subcultural differences amongst South Asians them-
selves needs further consideration. Carr and Mayberry 
[15] found greater disease severity in second gen-
eration South Asians with UC (living in the UK for at 
least 25  years) compared to first generation migrants 
and the indigenous population, although the reason 
for such differences remain unclear. There may also 
be differences in healthcare services received by eth-
nic minority patients [24, 31, 32]. Silvernale et al. [32] 
found that ethnic minority groups (Hispanics, Blacks, 
Asians) with IBS were significantly less likely to receive 
consultation appointments in secondary care com-
pared to White patients, but they were more likely to 
receive gastroenterology procedures (e.g., diagnostic 
testing)  compared to White patients. Similarly, Misra 
et  al. [31] found that biological therapy for CD was 
prescribed significantly less often for British South 
Asians compared to White patients.
We aimed to conduct a systematic scoping literature 
review of ethnic minority peoples’ experiences of liv-
ing with chronic bowel diseases, including IBD, IBS and 
coeliac disease. The purpose was to examine the avail-
able evidence, identify gaps in the literature and outline, 
appraise and synthesise all relevant studies rather than 
generate a definitive answer to a specific question [33, 
34]. A broader view was taken since a preliminary litera-
ture search identified insufficient evidence for a classic 
systematic review addressing only IBD or IBS amongst 
this patient population.
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Methods
We followed the systematic scoping review process 
described originally by Arksey and O’Malley [35] and 
developed more recently by Pollock et  al. [34]. The 
process mirrors that of a classic review but allows 
adjustment to the protocol as a sense of the literature 
emerges, and quality appraisal is optional. Both fac-
tors are methodologically sound because the purpose is 
not to provide a precise answer to immediately inform 
practice or policy, but to identify the types of avail-
able evidence, and identify and analyse any knowledge 
gaps [34]. Conclusions may therefore be broader than 
expected from a classic systematic review. However, we 
did conduct a quality appraisal as a further purpose of 
this review was to inform the design of our intended 
future studies.
Literature search
Search terms were finalised using the Sample, Phenom-
enon of Interest, Design, Evaluation and Research type 
(SPIDER) framework (see Table 1 and Additional file 1: 
Appendix S1) [36]. The SPIDER framework [36] is a sys-
tematised search strategy tool that facilitates rigour and 
confidence in the retrieval of studies in a review, similar 
to the PICO [37], though the SPIDER framework allows 
more flexibility for considering various study designs 
(e.g., qualitative and mixed methods research) than 
PICO which is suited specifically for quantitative stud-
ies [36, 37]. We searched for qualitative, quantitative, 
and mixed methods studies on eight electronic data-
bases (CINAHL, PubMed, PsychINFO, Psychology and 
Behavioural Sciences Collection, Ovid, Embase, Aca-
demic Search Primer, and Google Scholar), and manu-
ally searched reference lists of frequently cited papers. 
The search was limited to articles published in the Eng-
lish language, since 2000, reflecting the timeframe for 
significant developments in medical interventions in 
conditions such as IBD in the last 20 years [38, 39], and 
the rising incidence of primary bowel conditions in eth-
nic minority populations [1–3].
Inclusion and exclusion criteria
We conducted a preliminary scan of the literature to get 
a sense of the data and based our inclusion criteria on 
this. The search included people of all ages and studies 
that were: 1) full text original research articles; 2) pub-
lished in English, since 2000; 3) comprised of  all ethnic 
minority participants (as described by authors) or stud-
ies  reporting findings of ethnic minority participants 
separately from non-minority group participants; 4) 
participants who were  resident of countries such as the 
UK, USA, Australia, and New Zealand; 5) participants 
living with any primary chronic bowel condition; 6) any 
qualitative, quantitative, or mixed methods design. We 
excluded studies that: 1) did not clearly describe partici-
pant ethnicity e.g., non-white; 2) the bowel condition or 
symptom is not explicitly linked to patients’ experiences; 
3) experiences of carers, parents, or healthcare profes-
sionals; 4) studies on international travellers who are not 
resident of a country.
Study selection
A PRISMA diagram was used to report the application of 
the inclusion and exclusion criteria and the selection of 
final papers for review (Fig. 1).
Data extraction, quality assessment and analysis
All titles, abstracts and full texts were screened by 
one reviewer (SA); in addition, a random 10% of titles 
Table 1 Search terms based on the SPIDER framework
SPIDER framework Search terms
Sample (S) Ethnic* minorit* OR Indigenous OR Native
South Asia* OR Bengali OR Bangladesh* OR India* OR Pakistan* OR Sri Lanka* OR Nepal* OR Afghan* OR Black OR 
Africa* OR Afro Caribbean OR Somali OR Sudan* OR Zimbabw* OR Turk* OR Arab OR Middle Eastern OR Assyrian 
OR Kurd OR Iraq* OR Leban* OR Syria* OR Iran* OR Irish OR Gypsy OR Traveller OR Refugee OR Asylum OR Chin* OR 
Japan* OR Korea* OR Mongolia* OR Latin* OR Puerto Rican OR Mexic* OR Hawai’ian OR Alaska OR Brazil* OR Chile* 
OR Venezuelan OR Jamaica* OR Cuban OR Hispanic OR Quebec* OR Mohawk OR Inuit OR Metis OR Acadian OR 
Aboriginal or Melanesian or Maori or Islander OR Filipino OR Indonesia* OR Vietnam* OR Cambodia* OR Burm* OR 
Malaysia* OR Singapore* OR Timorese OR Laotians OR Europe*
Phenomenon of Interest (PI) Inflammatory bowel disease OR Crohn OR Ulcerative colitis
Bowel function OR bowel dysfunction OR bowel disorder OR bowel cancer OR Irritable bowel syndrome
Carcinoma OR constipation OR stoma
Design (D) Interview OR focus group OR survey OR case stud* OR observation OR ethnograph*
Evaluation (E) Experien* OR view* OR opinion* OR attitude* OR feel* OR understanding* OR belief* OR perspectives* OR perception*
Research type (R) Qualitative OR quantitative OR mixed method
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and abstracts were screened by two other review-
ers (PN, OO), and 10% of full texts were screened by 
three reviewers (PN, OO, LD). Disagreements were 
resolved by discussions and clarification of the inclu-
sion/exclusion criteria as needed. Two recognised criti-
cal appraisal tools were used to critique each included 
paper and informed data extraction: The Centre for Evi-
dence-Based Management Critical Appraisal (CEBMa) 
for survey-based studies [40], and the Critical Appraisal 
Skills Programme (CASP) for qualitative, case-con-
trolled and cohort studies [41]. Quality appraisal was 
reviewed by two reviewers (SA, OO). Due to heteroge-
neity of designs across studies, a data-driven approach 
to thematic analysis was taken to identify core themes 
of patient experiences and this was summarised narra-
tively [42].
Fig. 1 PRISMA flow diagram
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Results
Study characteristics
Of the 1347 articles that were originally retrieved, 14 
papers were retained for inclusion in the review fol-
lowing screening (Fig. 1). Table 2 illustrates that studies 
were conducted between 2001 and 2018. Seven stud-
ies were conducted in the UK [43–49], six in the USA 
[50–55], and one in Malaysia [56]. Study design varied 
and included six case-controlled studies [46, 47, 50, 51, 
53, 55], four survey-based studies [44, 45, 52, 54], three 
qualitative studies [43, 48, 49] and one cohort study [56]; 
focussing on IBD [43, 45–53, 55], IBS [54, 56], and coeliac 
disease [44]. Studies recruited participants from various 
ethnic minority groups including South Asians, African 
Americans, Blacks, Hispanics, and Chinese. Three stud-
ies that mentioned religious backgrounds comprised of 
a mixture of religions, where the majority of participants 
were Muslims [43, 48, 49]. Thirteen studies indicated par-
ticipants’ ages; three used the inclusion criteria to specify 
participant age as 16–24 [43, 46, 49]; one study  reports 
participant age as over 16 [44]; another study reports par-
ticipant age as 18–65 [48]; and nine studies report mean 
ages with one standard deviation in the results enabling 
the reader to determine that all participants were over 
the age of 16 [47, 50–54, 56]. The remaining two studies 
[45, 55] give no indication of participants’ ages. Five stud-
ies accommodated for language alongside English, which 
were mainly South Asian languages (e.g., Hindi, Gujrati, 
Punjabi, Bengali, Urdu, and Mirpuri) [44–46, 48] and 
Spanish [50].
Quality assessment
Based on CASP and CEBMa quality criteria, there were 
seven good (four star) quality studies [43, 47–49, 51, 53, 
56], and seven moderately good (three star) quality stud-
ies [44–46, 50, 52, 54, 55].
Narrative synthesis of qualitative and quantitative 
data produced five broad themes: (1) disease presenta-
tion experiences, (2) healthcare service experiences, (3) 
medicine adherence experiences, (4) psychological health 
experiences, and (5) sociocultural experiences (Fig. 2).
THEME 1: Disease presentation experiences
Inflammatory Bowel Disease
There were mixed findings on the disease presentation of 
CD between ethnicities in two US studies [51, 53]. Jack-
son and Shaukat [51] reported that although the number 
of annual flare ups and symptom duration before CD 
diagnosis did not differ, the nature of CD was different in 
African Americans compared to White  patients, where 
small bowel disease (84% vs. 65%, p = 0.03) and small 
bowel resection (59% vs. 16%, p = 0.01) were signifi-
cantly more prevalent in White patients, though colonic 
disease (89% vs. 63%, p = 0.002) and perirectal fistulae 
(58% vs. 22%, p = 0.001) were significantly higher in Afri-
can Americans. Straus et al. [53] found that US Black and 
White patients had similar CD presentations e.g., age of 
onset. Goodhand et al. [47] reported that 60% of British 
Bangladeshi participants had significantly more exten-
sive UC disease compared to 33% of White Caucasians 
(p = 0.02), alongside anaemia (p =  <0.001) and vitamin D 
deficiency (p =  <0.05).
In relation to IBD diagnosis, Goodhand et  al. [47] 
found that British Bangladeshis were diagnosed with CD 
significantly more often than with UC, in comparison 
to White Caucasians (p =  <0.01), although there were 
no significant differences in participant age at diagnosis 
between these ethnicities (p = 0.52). Jackson and Shau-
kat [51] found that there were no significant differences 
in the setting in which CD was diagnosed for US African 
American and White patients [clinic: 31% vs. 61%; hos-
pital: 47% vs. 27%, p = ns (not reported)], the number of 
disease flares (3.69 vs. 3.1 visits per year), and the dura-
tion of symptoms before diagnosis (mean duration of dis-
ease 3.5 vs. 5.3  years). Alexakis et  al. [43] reported that 
IBD was sometimes misdiagnosed amongst British South 
Asian and Black participants as tuberculosis, IBS, stress 
with diarrhoea or psychosomatic disorders.
Two studies found that IBD-related surgeries were sim-
ilar across ethnicities [46, 53]. Farrukh and Mayberry [46] 
found that surgery (n = 3 vs. n = 7) and death rates (n = 1 
vs. n = 3) were similar for British South Asians and White 
Europeans. Experiences of post-surgery complications 
have been reported in two studies [47, 55]. Goodhand 
Fig. 2 Ethnic minority patients’ experiences of chronic bowel 
conditions
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et al. [47] found that compared to British White Cauca-
sians, Bangladeshis had significantly later surgery [HR 
(95% CI) 0.4 (0.2, 0.9), p = 0.03], developed more perianal 
complications [HR (95% CI) 8.6 (1.4, 53.1), p = 0.02], and 
received anti-TNFs earlier [HR (95% CI) 3.0 (1.2, 7.7), 
p = 0.02]. Additionally, Yarur et  al. [55] found increased 
post-operation complications for US Hispanics and non-
Hispanics who had equal access to medical aid and fol-
low-up, but this did not reach significance [OR 1.06 (95% 
CI) 0.48–2.36, p = 0.88]. However, postoperative compli-
cations were significant factors associated with diagnosis 
of UC [OR 5.4 (95% CI) 1.67–20.58, p = 0.004], preopera-
tive albumin levels [OR 8.2 (95% CI) 2.3–35.5, p = 0.001], 
smoking [OR 15.7 (95% CI) 4.2–72.35, p = 0.001], and 
prednisone use [OR 6.7 (95% CI) 2.15–24.62, p = 0.001] 
[47]. Farrukh and Mayberry [46] found that compared to 
White Europeans, IBD hospitalisations were more com-
mon in South Asians [p = ns (not reported)], who also 
had significantly fewer tests covering wider modalities 
(t = 2.1, p =  <0.02). Additionally, US White participants 
were significantly more likely to receive multiple doses of 
infliximab for CD compared to African Americans (34% 
vs. 11%, p = 0.005) [51]. Another study [53] found that 
IBD-related hospitalisations were similar for US Black 
and White patients [8.3 (SD 15.5) vs. 10.2 (SD 17.6), 
p = ns (not reported)].
Irritable Bowel Syndrome
The selected papers addressing IBS [54, 56] did not focus 
on experiences relating to disease presentation.
Coeliac Disease
Butterworth et  al. [44] found that the presentation of 
coeliac disease (e.g., the morphological recovery of small 
bowel mucosa to normal/near normal) between British 
White Caucasians and South Asians was similar, though 
not statistically significant [75% vs. 77.8%, p = ns (not 
reported)].
THEME 2: Healthcare service experiences
Several UK and US studies reported the need for better 
healthcare services for ethnic minority patients [43, 44, 
46, 48, 51, 53].
Inflammatory Bowel Disease
Attendance at UC follow-up appointments was more 
common for British White patients compared to other 
ethnicities; Farrukh and Mayberry [46] found that South 
Asians were significantly less likely to receive consultant 
appointments (z = 1.66, p =  <0.048) and more likely to be 
discharged from hospital follow-up (z = -2.3, p =  <0.01). 
Most of the consultants seen by South Asians were Euro-
pean and male. The number of screening colonoscopies 
offered to White Europeans (43%) was higher compared 
to South Asians (32%), although this was non-significant 
[z = 0.9, p = ns (not reported)].
Jackson and Shaukat [51] found that US White patients 
were more likely to seek care for their CD in a clinic set-
ting, whether via primary community physician (1.31 
vs. 0.21 visits per year, p = 0.001), or secondary (hospi-
tal) gastroenterologist care (3.2 vs. 2.3 visits per year, 
p = 0.03). In two IBD studies with British South Asians, 
participants reported experiencing better medical care 
and expertise in secondary gastroenterology care com-
pared to primary care [43, 48], though language barri-
ers still existed [48]. Strauss et al. [53] suggested that US 
ethnic minority groups may have financial constraints in 
accessing healthcare. White patients were more likely to 
have health insurance compared to Black patients (92% 
vs. 85%, p = 0.02), who were more likely to be receiving 
Medicaid (17% vs. 6%, p = 0.01), report unreasonable 
healthcare delays (mean 1.4 vs. 1.3, p = 0.01) and have 
financial difficulties/concerns about affording health-
care (mean 2.8 vs. 2.6, p = 0.03), which meant delaying 
appointments (mean 2.8 vs. 2.6, p = 0.02) and travelling 
to appointment sites (mean 2.8 vs. 2.6, p = 0.01). The 
number of CD-related work absences were also more 
common amongst Black patients, compared to White 
patients (p =  <0.01).
Irritable Bowel Syndrome
Taft et  al. [54] found that Hispanic patients with IBS 
reported more perceived stigma from healthcare pro-
viders than Caucasian and non-Hispanic patients (mean 
2.30 vs. 1.19, p = 0.000).
Coeliac Disease
Attendance at coeliac disease follow-up appointments 
was more common for White patients compared to other 
ethnicities [44]. Butterworth et  al. [44] reported that 
compared to White Caucasians, South Asians living with 
coeliac disease were less likely to attend dietician consul-
tations (62.5% vs. 21%, p = 0.005), they were significantly 
dissatisfied with information provided by clinicians and 
dieticians (8.47% vs. 30%, p = 0.03), and dietetic advice 
(6.35% vs. 30%, p = 0.01); reasons for both these experi-
ences were unclear.
THEME 3: Medicine adherence experiences
Five studies reported experiences of medication use with 
varied findings [48, 49, 51–53].
Inflammatory Bowel Disease
Two studies showed that US White participants with 
IBD had higher medication adherence compared to Afri-
can American (77% vs. 49%, p = 0.004) [51], and Black 
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minority patients (HBSC: 15.6 vs. 14.0, p = 0.0002) [52]. 
Compared to White patients, African Americans signifi-
cantly discontinued CD medication due to feeling bet-
ter (27% vs. 9%, p = 0.02), though they knew that this 
would cause disease flare ups (25% vs. 9%, p = 0.036) [51], 
and IBD medicine adherence amongst Black patients 
was significantly related to greater trust in physicians 
(R =  −0.30, p =  < 0.0001), increasing age (R = −0.19, 
p = 0.01) and worsening health-related quality of life 
(QOL) (R = −0.18, p = 0.01) [52]. In two other stud-
ies, similar medication adherence was reported for the 
majority of British South Asians and White Europeans 
with IBD [48], and between US Black and White partici-
pants with CD [92% vs. 88%, p = ns (not reported)] [53]. 
However, many South Asians also used complementary 
and alternative medication (CAM) alongside prescribed 
medication (e.g., Ayurvedic medicine and Isabgol), and 
some consulted faith healers [48]. South Asian Muslims 
living in the UK had no clear information on whether 
they could use medication during the fasting hours of 
Ramadan, which influenced adherence [49].
Irritable Bowel Syndrome and Coeliac Disease
Medication adherence was not addressed in the selected 
articles which focussed on stigma in IBS [54], dietary 
aspects in IBS [56], and GFD in coeliac disease [44].
THEME 4: Psychological health experiences
Three of the selected papers reported on the psychologi-
cal wellbeing of patients with IBD and IBS [45, 48, 54].
Inflammatory Bowel Disease
Two UK-based studies reported experiences of IBD-
related anxiety amongst South Asians [45, 48]. Provision 
of patient information booklets translated into com-
mon South Asian languages (Hindi, Gujarati, Punjabi) 
reduced or had no effect on IBD-related anxiety in 66% 
of participants, whilst 33% reported increased levels of 
anxiety, although the sample size was small (N = 56) [45]. 
Mukherjee et al. [48] found that due to the fear of becom-
ing symptomatic, other IBD-related emotional experi-
ences (e.g., depression and feeling low) played a role in 
inhibiting engagement of social activities during asymp-
tomatic periods.
Irritable Bowel Syndrome
Taft et al. [54] reported that higher levels of anxiety were 
linked to higher levels of perceived stigma, and that His-
panic participants reported higher levels of perceived 
stigma from personal relationships and from health-
care providers when compared with non-Hispanic par-
ticipants. This suggests that Hispanic patients with IBS 
experience higher levels of disease-related anxiety than 
non-Hispanic patients, although it is not explicitly stated. 
Disease-related psychological impact was not addressed 
in the single paper reporting the potential for a low FOD-
MAP diet to benefit people from ethnic minority groups 
with IBS [56].
Coeliac Disease
The single paper addressing GFD in coeliac disease [44] 
did not report any data linked to disease-related psycho-
logical impact.
THEME 5: Sociocultural experiences
Sociocultural aspects were described in four sub-
themes relating to health-literacy and culturally rele-
vant information, diet, social support, and religion.
Sub‑theme: Health literacy about bowel conditions and need 
for culturally relevant information
Inflammatory Bowel Disease
The need for culturally relevant information and edu-
cation for British South Asians living with IBD was 
identified by three studies [43, 45, 48]. Low health lit-
eracy about IBD amongst British South Asians and the 
wider community was reported by two studies [48, 49]. 
Mukherjee et al. [48] found that the South Asian commu-
nity had difficulty understanding IBD because there was 
no substitute word for ‘Crohn’s’ in some languages and 
there were different connotations of the word ‘disease’ 
as in the label ‘inflammatory bowel disease’—for exam-
ple, disease may also infer infectious or life-threatening 
illnesses. Communication about bowel symptoms with 
other people was perceived as private due to factors such 
as embarrassment, stigma (including concerns about 
marriageability and conceiving children) and conflict 
around cultural expectations, such as gender roles for 
women’s ability to manage childcare and housework, and 
men’s ability to be a provider.
Mukherjee et al. [48] also found that South Asians had 
barriers in using the online Crohn’s and Colitis UK (char-
ity) website due to language factors, IT literacy and cul-
turally appropriate venues where participants would not 
stand out as the only South Asian in a group. Nash et al. 
[49] reported that younger British South Asians who were 
proficient in English were able to access and understand 
information, but there was little culturally relevant infor-
mation for parents who spoke English as a second lan-
guage. Additionally, Jackson and Shaukat [51] reported 
that both US White and African American participants 
felt equally informed about CD. Conroy and Mayberry 
[37] described the difficulties of even recruiting UC 
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patients to their study due to communication difficul-
ties and lack of resources in relevant languages. They 
concluded that greater detail may be needed to make the 
content of information leaflets more culturally relevant.
Irritable Bowel Syndrome
Wong et al. [56] focussed on compliance with a low Fer-
mentable Oligosaccharides, Disaccharides, Monosac-
charides and Polyols (FODMAP) diet to improve IBS 
symptoms. They do not report any data indicating the 
likely influences on the low compliance rate (50% com-
plete compliance over a 6-week programme), although 
cultural influences and limited knowledge  amongst 
patients are addressed in the Discussion section.
Coeliac Disease
Butterworth et  al. [44] report that factors correlated 
with stated compliance to a GFD in White Caucasians 
do not correlate with stated compliance in South Asian 
patients, including understanding of food labelling [2.13 
(OR1.08–4.17) vs. 1.21 (OR 034–4.34)] and receiving a 
detailed explanation of coeliac disease from their physi-
cian [2.04 (OR 1.16–3.57) vs. 1.59 (OR 0.36–7.14)]. South 
Asians were more dissatisfied than White Caucasians 
with information provided by their physician (30% vs. 
8.47%, p = 0.03) and with dietetic advice (30% vs. 6.35%, 
p = 0.01). The authors concluded that verbal and written 
information about coeliac disease and a GFD, provided in 
appropriate languages, are necessary to increase health 
literacy and enhance compliance with treatment.
Sub-theme: Diet
Five out of fifteen studies focussed on experiences of diet 
in relation to IBD, IBS and coeliac disease [43, 44, 49, 50, 
56].
Inflammatory Bowel Disease
Damas et  al. [50] found that US Hispanics, of which a 
majority had adapted to bicultural acculturation [IBD 
17 (58.6%); controls 21 (72.4%), χ2 (3, n = 58) = 3.31, 
p = 0.35], changed their diet after migration with no 
active gastrointestinal symptoms at the time of migra-
tion, though this did not reach significance [IBD 72.4%; 
controls 57.1%, χ2 (1, n = 57) = 1.46, p = 0.23). Hispanic 
participants reported that they developed poor dietary 
intake (e.g., lower than recommended consumption of 
vegetables, legumes, whole grains, and sea plant protein), 
irrespective of whether they had IBD or not [mean IBD 
53.8 (SD 13.9); controls 56.5 (SD 10.5), t(55) =  −0.81, 
p = 0.42, d = 0.22]. Although, IBD patients reported lower 
intake for total fruit [mean IBD 2.5 (SD 2.3); controls 3.7 
(SD 1.7), p = 0.02], whole fruit [mean IBD 2.5 (SD 2.4); 
controls 3.8 (SD 2.0), p = 0.02], and total dairy [mean 
IBD 3.1 (SD 3.4); controls 5.7 (SD 3.5), p = 0.01], but 
higher consumption of sodium [mean IBD 2.0 (SD 2.6); 
controls 3.5 (SD 3.1), t(55) =  −1.9, p = 0.06, d = 0.52], 
and refined grains [mean IBD 5.5 (SD 3.8); controls 7.6 
(SD 3.3), t(55)  =  −2.2, p = 0.03, d = 0.59]. Participants 
with IBD also met recommended minimal consumption 
of empty calories such as alcohol, solid fats and added 
sugars [mean IBD 17.5 (SD 3.9); controls 13.2 (SD 5.2), 
t(55) = 3.56, p =  < 0.01, d = 0.93].
Three UK-based studies showed that self-management 
of diet in IBD revolved around avoidance of certain food 
to reduce symptoms [43, 48, 49]. However, sometimes 
there was a conflict and struggle with cultural norms 
where food was shared (for example, spicy food, reli-
giously blessed food, family functions and women living 
with in-laws), which meant that patients had daily prac-
tical and emotional challenges, including anxiety, social 
exclusion, a sense of loss, social pressure to eat, difficulty 
getting others to accept their chosen diet and guilt around 
becoming a burden [43, 48, 49]. Those participants who 
attended social events, sometimes compromised by 
bringing separate packed food, or had others prepare 
separate meals for them [43]. One study [49] found that 
little IBD awareness amongst elders also caused tensions 
in understanding the chosen diet of young people, who 
found it was difficult to decline requests of elders encour-
aging them to eat certain foods that were perceived to be 
healthy. Conflict led to practical and emotional toll such 
as hurtful comments about appearance and weight.
Irritable Bowel Syndrome
A Malaysian study [48] found poor compliance with a 
low FODMAP diet in Chinese, Indian and Malays. How-
ever, those who completely or partially complied with the 
diet improved IBS-related bowel symptoms of flatulence 
(87.5%), bloating/distension (70%) and abdominal pain 
(60%). Limited access to low FODMAP food items and 
poor labelling of FODMAP content in Asian foods were 
reported as contributing to low adherence in the non-
compliant group.
Coeliac Disease
Butterworth et  al. [44] found that more British White 
Caucasians living with coeliac disease significantly 
reported that they never ingested gluten (p = 0.04), or 
ingested gluten less than once a month compared to 
South Asians (p = 0.03), suggesting that the manage-
ment of GFD in South Asians may need to be different to 
White Caucasians, who were more likely to understand 
food labelling, had access to gluten-free products and 
were members of the Coeliac Society (charity).
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Sub‑theme: Social support
Inflammatory Bowel Disease
Social support for South Asians living with IBD was lim-
ited [43, 48, 49] due to language barriers, lack of cultur-
ally relevant information, relying on information from lay 
sources, and for younger patients, difficulties of explain-
ing or censoring information to parents to avoid burden-
ing them, such as not mentioning the chronic nature of 
IBD [43, 49]. Some South Asian parents believed that 
IBD was related to ulcers or poor diet and did not know 
whether they should inform their child’s school [43]. Dis-
ruption to education was also reported by various ethnic 
minority groups [43, 49] who reported a lack of inte-
grated IBD understanding and care for young people at 
schools, which could result in bullying [43].
Irritable Bowel Syndrome
Taft et  al. [46] found that  compared to non-Hispanics, 
US Hispanics reported significantly more perceived IBS-
related stigma for personal relationships [mean 2.90 vs. 
1.67, t(196) = 9.24, p = 0.000]. Items in the Perceived 
Stigma Score-IBS demonstrate higher scores (greater 
perceived stigma; maximum score per sub-scale 5.0) 
from significant others not having enough knowledge 
about IBS (3.2 ± 1.3), not taking the person with IBS seri-
ously (2.5 ± 1.3), not being interested in hearing about 
IBS (2.8 ± 1.4), although the authors do not report His-
panic and non-Hispanic data separately.
Coeliac Disease
Fewer South Asians than White Caucasians accessed 
social support via membership of the Coeliac Society 
(53.4% vs. 79%, p = 0.02); membership was reported as 




Three studies found that religious coping was impor-
tant for self-managing IBD, particularly for British South 
Asian Muslims. Religious actions had a calming effect, 
such as helping participants understand why they were 
experiencing illness, dealing with pain, and believing that 
IBD was a test from God [43, 48, 49]. Support from reli-
gious leaders, including empathy and leaflets on religious 
guidance during Ramadan, was also noted as beneficial 
for some Muslims [43]. Additionally, managing symp-
toms was important to participate in Islamic worship 
[43, 48, 49]; fear of incontinence and anticipated bowel 
movements created anxieties for Muslims around main-
taining ablution (an Islamic ritual that forms the basis 
of performing various types of worship such as prayer) 
[43, 48], preserving a clean place of worship and avoiding 
interruptions to prayer [43].
Irritable Bowel Syndrome and Coeliac Disease
None of the papers addressing IBS [54, 56] or coeliac dis-
ease [44] reported data addressing religious influence as 
these quantitative studies addressed measuring stigma, 
and the effects of specific diets on these diseases.
Discussion
Fourteen studies were identified, with a mixture of good 
and moderately good quality, which explored diverse 
experiences of ethnic minority patients from the UK, US, 
and Malaysia, living with IBD, IBS, and coeliac disease. 
Culturally relevant IBD and coeliac disease information/
education was needed for British South Asians due to 
low awareness, language and literacy barriers, and illness 
perceptions—including understanding IBD to be a pri-
vate matter that should not be discussed openly. Muslim 
South Asians living with IBD used religious self-manage-
ment to understand illness experiences and had difficulty 
in managing symptoms (e.g., fear/risk of incontinence) to 
fulfil religious activities. British South Asian and Black 
individuals had problems with IBD diagnosis and mis-
diagnosis. Ethnic minority populations across countries 
and illnesses experienced poor dietary intake, difficul-
ties adhering to a GFD, cultural conflict in self-managing 
one’s diet (such as avoiding spicy food), increased IBD-
related anxiety, and received poor-quality healthcare 
services particularly in primary care in the UK. Mixed 
findings on experiences of disease presentation showed 
that the nature of conditions was sometimes similar (for 
example, coeliac disease in South Asians), and at times 
extensive (such as UC in Bangladeshis), compared to 
the  White population. Experiences of medicine adher-
ence varied across different studies; some ethnic minor-
ity groups with IBD had poorer medicine adherence (e.g., 
US Black and African American patients) and some had 
similar medicine adherence (e.g., US Black patients), 
compared to White patients. Some South Asians with 
IBD also used CAM alongside medication.
Low IBD awareness amongst South Asians (and rel-
evant others), generally due to language barriers [48, 49], 
has previously been reported for other chronic illnesses 
such as cancer and cancer-related services e.g., colorec-
tal screening [57, 58], and may indicate generational dif-
ferences, including older generations for whom English 
is a second language. Understanding of illnesses may 
need to be facilitated by culturally relevant information 
[43–45, 48, 49], cultivated with linguistic considerations 
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including the use and meaning of non-equitable terms—
such as ‘Crohn’s’ ‘Disease’—in other languages [48]. What 
constitutes as an illness may differ cross-culturally and 
from Western descriptions [21]. The perception, expres-
sion and management of an illness and its symptoms (e.g., 
pain) may be shaped by different cultural influences (e.g., 
belief systems), psychosocial factors and relationship 
structures [21, 59]. For instance, Indians can conceptual-
ise IBS in terms of emotions such as anxiety and depres-
sion, hence why there may often be a diagnosis stigma 
related to psychological instability in this community. 
In comparison, family relationships; a Mexican cultural 
value  may mean emotions experienced in relationships 
such as stress are attributed to IBS. While Chinese indi-
viduals may appraise their connection with their environ-
ment, therefore during symptomatic periods of IBS they 
may express a sense of imbalance with the environment 
and a need to re-balance through self-management [59].
Using diet to manage symptoms [43, 48, 49] has been 
widely reported such as avoiding spicy food [22, 26] and 
dining outside the home [26], although this review found 
that poor understanding of dietary choices of young 
people with IBD were often not aligned with traditional 
norms and expectations of parents, in-laws, or extended 
family, creating psychological issues (e.g., anxiety) and 
generational conflict [43, 48, 49]. Dietary changes due 
to migration/acculturation lead to poor meal intakes 
for Hispanics living with IBD [50], and is supported by 
previous studies; in Norway, Pakistani and Sri Lan-
kan migrants reduced intake of beans and lentils [60], 
and Pakistani women increased dairy intake [61]. Brit-
ish South Asians had higher energy and fat intake and 
lower carbohydrates [62], while Canadian South Asian 
children had higher intake of fat and refined sugars, and 
lower intake of fresh fruits and vegetables compared to 
their parents and grandparents [17]. Literacy issues can 
also  have an impact on the efficacy of recommended 
dietary changes (such as understanding food content, 
acceptability and access to proposed food as with  GFD, 
understanding what constitutes as high and low FOD-
MAP diets) [63–65], as found in this review—South 
Asians with coeliac disease did not understand food 
labelling [44].
Stigma related to IBS and IBD were widespread in rela-
tion to gender expectations (e.g., conceiving children), 
and personal relationships [48, 54], although such stigma 
has also been reported in other ethnic groups [23, 66, 67]. 
Discretion in discussing bowel symptoms were also rel-
evant to Pakistani women with urine incontinence [48, 
68]. Anxieties around IBD symptoms (e.g., fear of incon-
tinence and bowel movements) on managing daily reli-
gious duties based on physical purification for Muslim 
South Asians [43, 48, 49] has been previously reported 
with IBS [69], colostomy procedures [70, 71], and in uri-
nary incontinence [22, 68]. Since certain bowel symptoms 
may nullify the state of purification, therefore  during 
symptom flare-ups there may be additional self-manage-
ment challenges due to the repeated need for ablution 
and needing to be near washing facilities [72]; these chal-
lenges may be heightened during religious months such 
as Ramadan and the Hajj pilgrimage [70, 71]. Guidance 
in using medication during Ramadan could be addressed 
in future interventions [49]. Religious actions were noted 
to have positive impact on experiences of IBD in our 
review [43, 48, 49], however other studies revealed that 
surgical interventions may instead reduce QOL [70, 71, 
73]. One literature review [71] of stoma patients found 
that perceptions of symptoms (e.g., uncleanliness) had 
a negative impact on psychological, religious, and spir-
itual well-being, since patients were restricted in fully 
immersing themselves in religious activities after sur-
gery, for instance participation in congregational mosque 
prayers and limiting the frequency or complete cessation 
of prayer. Fear of damaging the stoma was mentioned 
as a contributing factor to ceasing fasting in Ramadan, 
though it is medically safe [70, 71].
Evidence of generally poor health outcomes for eth-
nic minority groups in the UK and US [43, 44, 46, 47, 
51, 55] suggest the need for a deeper consideration of 
existing inequalities in healthcare services [22, 43, 44, 
46, 48, 51, 53]. Earlier CD studies have also found high 
unscheduled hospitalisations for US Asians and emer-
gency visits for African Americans [2]. Access dispari-
ties in IBD treatment have been found to  vary across 
UK regions, where British South Asians and Eastern 
Europeans were significantly less likely to be hospi-
talised compared to White  individuals, while in other 
areas compared to British White  people, Afro-Carib-
bean patients received significantly less treatment [74]. 
Findings of this study should be taken with the caveat 
that summarising data across countries may overlook 
the interactions created between an individual and 
their environment, for instance socioeconomic fac-
tors in accessing medical care may be more relevant 
to the US due to Medicaid [2], as found in this review 
[53]. In the UK, reasons for such disparities are more 
ambiguous [75], though it may include discrimination, 
language differences, restrictions in choosing the gen-
der of healthcare professionals [76], and limited aware-
ness of available services [75]. Inequitable provisions 
to manage language diversity, as found in gastroenter-
ology services in this review [48], has previously been 
found to influence communication with healthcare pro-
fessionals [68, 75].
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Limitations
To our knowledge, this has been one of the few stud-
ies reviewing literature on the experiences of ethnic 
minority patients’ living with chronic bowel illnesses. 
At full text screening, we excluded potentially relevant 
papers on cancer screening for bowel illnesses since 
they included participants who may not have pre-exist-
ing chronic bowel conditions; however, these papers 
may have been useful in understanding attitudes of 
the wider community and merit separate exploration. 
Caution should be taken when considering the find-
ings of the review, as some studies did not account for 
the diversity within a population e.g., defining ethnic-
ity as ‘Blacks’ and ‘Hispanics’, implying that researcher 
approach to defining ethnicity needs to be reported. 
One finding may be relevant for an ethnic group in one 
country but not others [2]. We included two studies 
that did not fully specify the ethnic group of partici-
pants from Hispanic backgrounds [54, 55]; for example, 
Yarur et  al. [55] described participants as those from 
Latin American descent, and Spanish and Portuguese 
origins, and Caribbean, Black or Other. We accepted 
the search term ‘Hispanic’ as a baseline descriptor of 
ethnicity and therefore included these studies. We 
acknowledge that this review includes different studies 
with several pathological conditions and ethnic groups, 
which may limit the wider application of conclusions.
Conclusions
This review has explored experiences of ethnic minority 
patients living with bowel illnesses across contexts and 
has identified that significant gaps remain in unearthing 
the experience and perspective of individuals who may 
not be able to speak English easily. Further qualitative 
work is needed to understand the cultural sensitivity of 
such experiences, and to build on extant preliminary 
data on experiences of psychological health, social sup-
port, and religious self-management. A generational 
and religious lens in understanding contextual experi-
ences of ethnic minority groups may be necessary to 
understand, for example, cultural conflict in relation 
to diet. There is also a need to culturally tailor infor-
mation for patients and those who support them, by 
addressing language and literacy barriers in healthcare 
services. More research is needed to understand and 
test the acceptability and feasibility of tailored infor-
mation. Inequalities in healthcare services and health 
outcomes suggest multilevel contextual factors may 
be at play, specific to the countries in question. Future 
research with ethnic minority populations experiencing 
other bowel-related conditions such as stoma and ante-
rior resection syndrome following treatment for rectal 
cancer, is required.
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